Promore Pharma Granted US Patent Regarding Treatment Of Chronic Wounds
STOCKHOLM, SWEDEN / ACCESSWIRE / December 08, 2021 / Promore Pharma (STO:PROMO) (FRA:8T0)STOCKHOLM, 8 December 2021 - Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, have
Source: finanznachrichten.de